Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan, Curtis
Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients. [electronic resource] - Transplant infectious disease : an official journal of the Transplantation Society Feb 2019 - e13015 p. digital
Publication Type: Journal Article
1399-3062
10.1111/tid.13015 doi
Adult
Aged
Antiviral Agents--therapeutic use
Cytomegalovirus--isolation & purification
Cytomegalovirus Infections--blood
Female
Follow-Up Studies
Ganciclovir--therapeutic use
Graft Survival
Heart Diseases--blood
Heart Transplantation--adverse effects
Humans
Male
Middle Aged
Prospective Studies
Retrospective Studies
Risk Assessment
Serologic Tests
Survival Analysis
Tissue Donors--statistics & numerical data
Transplant Recipients--statistics & numerical data
Valganciclovir--therapeutic use
Young Adult
Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients. [electronic resource] - Transplant infectious disease : an official journal of the Transplantation Society Feb 2019 - e13015 p. digital
Publication Type: Journal Article
1399-3062
10.1111/tid.13015 doi
Adult
Aged
Antiviral Agents--therapeutic use
Cytomegalovirus--isolation & purification
Cytomegalovirus Infections--blood
Female
Follow-Up Studies
Ganciclovir--therapeutic use
Graft Survival
Heart Diseases--blood
Heart Transplantation--adverse effects
Humans
Male
Middle Aged
Prospective Studies
Retrospective Studies
Risk Assessment
Serologic Tests
Survival Analysis
Tissue Donors--statistics & numerical data
Transplant Recipients--statistics & numerical data
Valganciclovir--therapeutic use
Young Adult